Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Non-Current Assets (2019 - 2023)

Alx Oncology Holdings' Non-Current Assets history spans 5 years, with the latest figure at $21.0 million for Q3 2023.

  • For Q3 2023, Non-Current Assets fell 21.74% year-over-year to $21.0 million; the TTM value through Sep 2023 reached $128.5 million, up 15.41%, while the annual FY2022 figure was $35.5 million, 169.83% up from the prior year.
  • Non-Current Assets for Q3 2023 was $21.0 million at Alx Oncology Holdings, down from $26.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $45.6 million in Q1 2023 and bottomed at $45000.0 in Q3 2020.
  • The 5-year median for Non-Current Assets is $13.2 million (2021), against an average of $17.6 million.
  • The largest annual shift saw Non-Current Assets plummeted 92.85% in 2020 before it soared 23822.22% in 2021.
  • A 5-year view of Non-Current Assets shows it stood at $867000.0 in 2019, then plummeted by 92.85% to $62000.0 in 2020, then skyrocketed by 21132.26% to $13.2 million in 2021, then surged by 169.83% to $35.5 million in 2022, then crashed by 40.78% to $21.0 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Non-Current Assets are $21.0 million (Q3 2023), $26.4 million (Q2 2023), and $45.6 million (Q1 2023).